28 related articles for article (PubMed ID: 31855417)
1. Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.
Yin X; Wang M; Wang H; Deng H; He T; Tan Y; Zhu Z; Wu Z; Hu S; Li Z
Amino Acids; 2017 Aug; 49(8):1325-1335. PubMed ID: 28536844
[TBL] [Abstract][Full Text] [Related]
2. PET/NIR Fluorescence Bimodal Imaging for Targeted Tumor Detection.
Xue X; Li Q; Zhang P; Xue Y; Zhao Y; Ye Y; Li J; Li Y; Zhao L; Shao G
Mol Pharm; 2023 Dec; 20(12):6262-6271. PubMed ID: 37948165
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin analogs by fluoroglycosylation at N
Schindler L; Wohlfahrt K; Gluhacevic von Krüchten L; Prante O; Keller M; Maschauer S
Sci Rep; 2022 Sep; 12(1):15028. PubMed ID: 36056076
[TBL] [Abstract][Full Text] [Related]
4. PET imaging of CXCR4 receptors in cancer by a new optimized ligand.
Demmer O; Gourni E; Schumacher U; Kessler H; Wester HJ
ChemMedChem; 2011 Oct; 6(10):1789-91. PubMed ID: 21780290
[No Abstract] [Full Text] [Related]
5. The future of tumour-specific fluorescence-guided surgery for pancreatic cancer.
Lwin TM; Hoffman RM; Bouvet M
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):715-717. PubMed ID: 32416765
[No Abstract] [Full Text] [Related]
6. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy.
van Dam MA; Vuijk FA; Stibbe JA; Houvast RD; Luelmo SAC; Crobach S; Shahbazi Feshtali S; de Geus-Oei LF; Bonsing BA; Sier CFM; Kuppen PJK; Swijnenburg RJ; Windhorst AD; Burggraaf J; Vahrmeijer AL; Mieog JSD
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885196
[TBL] [Abstract][Full Text] [Related]
7. Site-Specific Dual-Labeling of a VHH with a Chelator and a Photosensitizer for Nuclear Imaging and Targeted Photodynamic Therapy of EGFR-Positive Tumors.
Renard E; Collado Camps E; Canovas C; Kip A; Gotthardt M; Rijpkema M; Denat F; Goncalves V; van Lith SAM
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498707
[TBL] [Abstract][Full Text] [Related]
8. A Cyanine-Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation.
Heing-Becker I; Grötzinger C; Beindorff N; Prasad S; Erdmann S; Exner S; Haag R; Licha K
Chembiochem; 2021 Apr; 22(7):1307-1315. PubMed ID: 33238069
[TBL] [Abstract][Full Text] [Related]
9. Functional Hybrid Molecules for the Visualization of Cancer: PESIN-Homodimers Combined with Multimodal Molecular Imaging Probes for Positron Emission Tomography and Optical Imaging: Suited for Tracking of GRPR-Positive Malignant Tissue*.
Hübner R; Cheng X; Wängler B; Wängler C
Chemistry; 2020 Dec; 26(69):16349-16356. PubMed ID: 32618007
[TBL] [Abstract][Full Text] [Related]
10. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
11. Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer.
Hodolic M; Ambrosini V; Fanti S
Nucl Med Commun; 2020 May; 41(5):411-415. PubMed ID: 32168264
[TBL] [Abstract][Full Text] [Related]
12. Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer.
Muilenburg KM; Isder CC; Radhakrishnan P; Batra SK; Ly QP; Carlson MA; Bouvet M; Hollingsworth MA; Mohs AM
Cancer Lett; 2023 May; 561():216150. PubMed ID: 36997106
[TBL] [Abstract][Full Text] [Related]
13. Design of Bimodal Ligands of Neurotensin Receptor 1 for Positron Emission Tomography Imaging and Fluorescence-Guided Surgery of Pancreatic Cancer.
Renard E; Dancer PA; Portal C; Denat F; Prignon A; Goncalves V
J Med Chem; 2020 Mar; 63(5):2426-2433. PubMed ID: 31855417
[TBL] [Abstract][Full Text] [Related]
14. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Evaluation of
Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
